Molecular Engineering of Electrosprayed Hydrogel Microspheres to Achieve Synergistic Anti‐Tumor Chemo‐Immunotherapy with ACEA Cargo
Advanced Science · 2024
DOI: 10.1002/advs.202308051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Youming Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xiangya Hospital, International Joint Research Center of Minimally Invasive Endoscopic Technology Equipment and Standa…. Hauptthemen laut MEDLINE: Immunotherapy, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Agonists, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Hunan Provincial Health Commission, Natural Science Foundation of Jiangsu Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Molecular engineering of drug delivering platforms to provide collaborative biological effects with loaded drugs is of great medical significance. Herein, cannabinoid receptor 1 (CB1)‐ and reactive oxygen species (ROS)‐targeting electrosprayed microspheres (MSs) are fabricated by loading with the CB1 agonist arachidonoyl 2′‐chloroethylamide (ACEA) and producing ROS in a photoresponsive manner. The synergistic anti‐tumor effects of ACEA and ROS released from the MSs are assessed. ACEA inhibits epidermal growth factor receptor signaling and altered tumor microenvironment (TME) by activating CB1 to induce tumor cell death. The MSs are composed of glycidyl methacrylate‐conjugated xanthan gum (XGMA) and Fe 3+ , which form dual molecular networks based on a Fe 3+ ‐(COO − ) 3 network and a C═C addition reaction network. Interestingly, the Fe 3+ ‐(COO − ) 3 network can be disassembled instantly under the conditions of lactate sodium and ultraviolet exposure, and the disassembly is accompanied by massive ROS production, which directly injures tumor cells. Meanwhile, the transition of dual networks to a single network boosts the ACEA release. Together, the activities of the ACEA and MSs promote immunogenic tumor cell death and create a tumor‐suppressive TME by increasing M1‐like tumor‐associated macrophages and CD8 + T cells. In summation, this study demonstrates strong prospects of improving anti‐tumor effects of drug delivering platforms through molecular design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Xiangya Hospital, International Joint Research Center of Minimally Invasive Endoscopic Technology Equipment and Standards, Central South University, Changsha, 410008, China.
- Research Institute of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
ORCID-Profile: Jinjian Huang
Förderung
- Scientific Research Project of Hunan Provincial Health Commission
- Natural Science Foundation of Jiangsu Province
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
- Transverse Project of Xiangya Hospital
Zitieren
APA
Deng, Y., Li, J., Tao, R., Zhang, K., Yang, R., Qu, Z., Zhang, Y., & Huang, J. (2024). Molecular Engineering of Electrosprayed Hydrogel Microspheres to Achieve Synergistic Anti‐Tumor Chemo‐Immunotherapy with ACEA Cargo. Advanced Science. https://doi.org/10.1002/advs.202308051
Vancouver
Deng Y, Li J, Tao R, Zhang K, Yang R, Qu Z, et al. Molecular Engineering of Electrosprayed Hydrogel Microspheres to Achieve Synergistic Anti‐Tumor Chemo‐Immunotherapy with ACEA Cargo. Advanced Science. 2024. doi:10.1002/advs.202308051
BibTeX
@article{Deng2024,
author = {Deng, Youming and Li, Jiayang and Tao, Ran and Zhang, Ke and Yang, Rong and Qu, Zhan and Zhang, Yu and Huang, Jinjian},
title = {Molecular Engineering of Electrosprayed Hydrogel Microspheres to Achieve Synergistic Anti‐Tumor Chemo‐Immunotherapy with ACEA Cargo},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202308051}
}
EUVIMED